Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

CUG2, a novel oncogene confers reoviral replication through Ras and p38 signaling pathway

Abstract

As we have recently found a novel oncogene, the cancer-upregulated gene 2 (CUG2), which was elevated in a variety of tumor tissues such as the ovary, liver, lung and pancreas, we examined whether reovirus could efficiently induce cytolysis in cancer cells expressing CUG2 and thus be used as a potential cancer therapeutic agent. In this study, we describe experiments in which we use reovirus to treat NIH3T3 cells stably expressing either CUG2 (NIH-CUG2) or vector only (NIH-Vec). NIH-CUG2 cells readily support reoviral proliferation and undergo apoptosis, whereas NIH-Vec cells are highly resistant to reoviral infection and virus-induced apoptosis. This notable result may be explained by the observation that CUG2 expression inhibits PKR activation, leading to reoviral proliferation in nonpermissive NIH3T3 cells. Furthermore, reovirus infection results in almost complete regression of tumorgenic NIH-CUG2 cells in transplanted nude mice. As we found that CUG2 enhances activation of MAPK (ERK, JNK and p38), Src kinase and Ras, we examined whether CUG2 confers reoviral replication independent of the Ras or p38 MAPK signaling pathway. From these experiments we found that either inhibition of p38 MAPK or Ras blocks reoviral proliferation even in the presence of CUG2 but inhibition of ERK, JNK and Src kinase does not, indicating that activation of p38 MAPK and Ras has critical roles in reoviral replication in CUG2-expressing tumor cells. Accordingly, we propose that reovirus can be useful in the treatment of transformed cells expressing CUG2, which is commonly detected in various tumor tissues.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

References

  1. Lee S, Gang J, Jeon SB, Choo SH, Lee B, Kim YG et al. Molecular cloning and functional analysis of a novel oncogene, cancer-upregulated gene 2 (CUG2). Biochem Biophys Res Commun 2007; 360: 633–639.

    Article  CAS  PubMed  Google Scholar 

  2. Norman KL, Hirasawa K, Yang AD, Shields MA, Lee PW . Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection. Proc Natl Acad Sci USA 2004; 101: 11099–11104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kim M, Chung YH, Johnston RN . Reovirus and tumor oncolysis. J Microbiol 2007; 45: 187–192.

    CAS  PubMed  Google Scholar 

  4. Rosen L, Evans HE, Spickard A . Reovirus infections in human volunteers. Am J Hyg 1963; 77: 29–37.

    CAS  PubMed  Google Scholar 

  5. Nibert ML, Schiff LA, Fields BN . Mammalian reoviruses contain a myristoylated structural protein. J Virol 1991; 65: 1960–1967.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Duncan MR, Stanish SM, Cox DC . Differential sensitivity of normal and transformed human cells to reovirus infection. J Virol 1978; 28: 444–449.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Hashiro G, Loh PC, Yau JT . The preferential cytotoxicity of reovirus for certain transformed cell lines. Arch Virol 1977; 54: 307–315.

    Article  CAS  PubMed  Google Scholar 

  8. Strong JE, Coffey MC, Tang D, Sabinin P, Lee PW . The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J 1998; 17: 3351–3362.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hirasawa K, Nishikawa SG, Norman KL, Coffey MC, Thompson BG, Yoon CS et al. Systemic reovirus therapy of metastatic cancer in immune-competent mice. Cancer Res 2003; 63: 348–353.

    CAS  PubMed  Google Scholar 

  10. Coffey MC, Strong JE, Forsyth PA, Lee PW . Reovirus therapy of tumors with activated Ras pathway. Science 1998; 282: 1332–1334.

    Article  CAS  PubMed  Google Scholar 

  11. Norman KL, Lee PW . Not all viruses are bad guys: the case for reovirus in cancer therapy. Drug Discov Today 2005; 10: 847–855.

    Article  CAS  PubMed  Google Scholar 

  12. Park EH, Koh SS, Srisuttee R, Cho IR, Min HJ, Jhun BH et al. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells. Cancer Gene Ther 2009; 16: 453–461.

    Article  CAS  PubMed  Google Scholar 

  13. Yang WQ, Lun X, Palmer CA, Wilcox ME, Muzik H, Shi ZQ et al. Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates. Clin Cancer Res 2004; 10: 8561–8576.

    Article  PubMed  Google Scholar 

  14. Ring CJ . Cytolytic viruses as potential anti-cancer agents. J Gen Virol 2002; 83 (Part 3): 491–502.

    Article  PubMed  Google Scholar 

  15. Russel FG, Masereeuw R, van Aubel RA . Molecular aspects of renal anionic drug transport. Annu Rev Physiol 2002; 64: 563–594.

    Article  CAS  PubMed  Google Scholar 

  16. Ikeda Y, Nishimura G, Yanoma S, Kubota A, Furukawa M, Tsukuda M . Reovirus oncolysis in human head and neck squamous carcinoma cells. Auris Nasus Larynx 2004; 31: 407–412.

    Article  PubMed  Google Scholar 

  17. Janssen HL, Higuchi H, Abdulkarim A, Gores GJ . Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression. J Hepatol 2003; 39: 414–420.

    Article  CAS  PubMed  Google Scholar 

  18. Clarke P, Meintzer SM, Spalding AC, Johnson GL, Tyler KL . Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection. Oncogene 2001; 20: 6910–6919.

    Article  CAS  PubMed  Google Scholar 

  19. Kim M, Egan C, Alain T, Urbanski SJ, Lee PW, Forsyth PA et al. Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells. Oncogene 2007; 26: 4124–4134.

    Article  CAS  PubMed  Google Scholar 

  20. Ayroldi E, Zollo O, Macchiarulo A, Di Marco B, Marchetti C, Riccardi C . Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol Cell Biol 2002; 22: 7929–7941.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Stewart MJ, Blum MA, Sherry B . PKR's protective role in viral myocarditis. Virology 2003; 314: 92–100.

    Article  CAS  PubMed  Google Scholar 

  22. Zhang P, Samuel CE . Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells. J Virol 2007; 81: 8192–8200.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Strong JE, Tang D, Lee PW . Evidence that the epidermal growth factor receptor on host cells confers reovirus infection efficiency. Virology 1993; 197: 405–411.

    Article  CAS  PubMed  Google Scholar 

  24. Strong JE, Lee PW . The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection. J Virol 1996; 70: 612–616.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Liu M, Bryant MS, Chen J, Lee S, Yaremko B, Lipari P et al. Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Cancer Res 1998; 58: 4947–4956.

    CAS  PubMed  Google Scholar 

  26. Trevino JG, Summy JM, Lesslie DP, Parikh NU, Hong DS, Lee FY et al. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol 2006; 168: 962–972.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Fizazi K . The role of Src in prostate cancer. Ann Oncol 2007; 18: 1765–1773.

    Article  CAS  PubMed  Google Scholar 

  28. Marcato P, Shmulevitz M, Lee PW . Connecting reovirus oncolysis and Ras signaling. Cell Cycle 2005; 4: 556–559.

    Article  CAS  PubMed  Google Scholar 

  29. Park E-H, Koh SS, Ratakorn S, Cho I-R, Min H-J, Jhun BH et al. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells. Cancer Gene Therapy 2009; 16: 453–461.

    Article  CAS  PubMed  Google Scholar 

  30. Marcato P, Shmulevitz M, Pan D, Stoltz D, Lee PW . Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release. Mol Ther 2007; 15: 1522–1530.

    Article  CAS  PubMed  Google Scholar 

  31. Smakman N, van den Wollenberg DJ, Borel Rinkes IH, Hoeben RC, Kranenburg O . Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D. J Virol 2005; 79: 14981–14985.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the World Class University program through NRF funded by Korean government (R31-2008-000-20004-0) to YHC and the Research Program for New Drug Target Discovery (M10748000195-08N4800-19510) grant from the Ministry of Science & Technology of Korea to SSK. This study was also supported by a grant of the Korean Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (00-PJ3-PG6-GN07-001) (BHJ).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to S S Koh or Y-H Chung.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, EH., Park, E., Cho, IR. et al. CUG2, a novel oncogene confers reoviral replication through Ras and p38 signaling pathway. Cancer Gene Ther 17, 307–314 (2010). https://doi.org/10.1038/cgt.2009.83

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2009.83

Keywords

This article is cited by

Search

Quick links